Publications

01 Oct 2001
News

Philip L. Yeo: The Next Big Thing

sciences and bioengineering. "In the next generation, we will know the genetic and molecular mechanisms of disease," Yeo declares. "Biomedical science will control and eradicate cancer and AIDS, and individualized medicine will be the... View Details

Keywords: Government

05 Dec 2013
Op-Ed

Encourage Breakthrough Health Care by Competing on Products Rather Than Patents

Like many people interested in the tangled connections between health care progress and intellectual property rights, I avidly followed the Myriad Genetics case, decided by the Supreme Court this June 13. In sum, molecular diagnostics... View Details

Keywords: by Richard G. Hamermesh; Biotechnology; Health

28 Dec 2016
News

In Memoriam: Bill Bowes (MBA 1952)

the Harvard Stem Cell Institute as well as service on the advisory committee for the Harvard Partners Center for Genetics and Genomics. Bowes was named an HBS Alumni Achievement Award winner in 2009, and his gift to the School in 2012... View Details

January 2009 (Revised July 2010)
Case

iZumi

By: Robert F. Higgins, Jacob Ian Broder-Fingert, Eliot Sherman and Sidhartha Palani

Presents the issues faced while building an innovative company in an emerging space with new intellectual property from the perspective of a venture capitalist. Beth Seidenberg, a partner at the venture capital firm Kleiner Perkins Caufield & Byers (KPCB), had helped... View Details

Keywords: Entrepreneurship; Venture Capital; Globalized Markets and Industries; Innovation and Management; Intellectual Property; Rights; Genetics; Financial Services Industry; Health Industry

14 Jul 2009
First Look

First Look: July 14

Course MaterialsThe DiagnoFirst Opportunity Harvard Business School Case 309-112 John Mason, a principle at Oldwell Partners, was facing a decision of whether or not to invest in DiagnoFirst, a molecular diagnostics firm. DiagnoFirst's key product was a View Details

Keywords: Martha Lagace

03 Mar 2015
First Look

First Look: March 3

a lower price but charge more for the cartridges necessary to run a sample and earn its primary revenue from these cartridges. The third model would see GenapSys sell its device at or around cost, but use the data customers generated to create a proprietary database of... View Details

Keywords: Sean Silverthorne

Web

Business Track | New Venture Competition

Venture Competition Winner, Business Track: Crop Diagnostix Crop Diagnostix is redefining precision agriculture through AI-powered, genetic insights. Team: Brandon Chi, MBA 2024; Joseph Swift; Amitesh Pratap; Leonie Luginbuehl. Play Video... View Details

June 2011 (Revised October 2013)
Case

Gene Patents (A)

By: Richard Hamermesh, David Kiron and Phillip Andrews

In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues... View Details

Keywords: Courts and Trials; Patents; Genetics; Judgments; Science-Based Business; Biotechnology Industry; United States

October 2001 (Revised March 2008)
Case

Anagene, Inc.

By: Robert S. Kaplan and Christina L. Darwall

An entrepreneurial, publicly traded biotech company has begun production and sales of its core product--cartridges that permit DNA samples to be analyzed on a microchip. In the early quarters, sales are difficult to forecast and the company has experienced fluctuating... View Details

Keywords: Cost Accounting; Financial Reporting; Production; Performance Capacity; Risk and Uncertainty; Genetics; Governing and Advisory Boards; Biotechnology Industry; California

17 Nov 2003
Research & Ideas

The Business of Babies

fertilization (IVF), surrogacy, and adoption demand payments of $10,000 and up. The largest demand in this market consists of infertile couples. Last year, some two million U.S. couples underwent fertility treatments. Additional demand includes same-sex couples, those... View Details

Keywords: by Julia Hanna; Health

Web

Finalists | New Venture Competition

barrier to healthcare with its AI-powered virtual medical interpreter. Crop Diagnostix Brandon Chi (MBA 2024) Joseph Swift Amitesh Pratap Redefining precision agriculture through AI-powered, genetic insights. Poka Labs Malay Shah (MBA... View Details

November 2006 (Revised March 2008)
Case

The Harvard Stem Cell Institute

By: William A. Sahlman

Describes a set of issues confronting the leaders of the Harvard Stem Cell Institute, an innovative cross-university effort to accelerate scientific discovery and translation in the domain of stem cells. Covers a wide range of topics, including understanding how... View Details

Keywords: Talent and Talent Management; Higher Education; Entrepreneurship; Collaborative Innovation and Invention; Intellectual Property; Research and Development; Genetics; Biotechnology Industry; Health Industry; Massachusetts

November 2009 (Revised March 2010)
Case

Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story

By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon

In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details

Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States

26 Sep 2024
Blog Post

Syngenta Tomato Vision

In January 2024, Professors Willy Shih and Mike Toffel led 45 HBS MBA students on site visits to witness the energy transition and innovative sustainable production activities throughout Denmark and the Netherlands, in the second year of their Immersive Field Course... View Details

27 Apr 2023
News

Life Preserver

of the world's population but only 0.5% of transplants are performed there. Giwa and his colleagues at the Global Solutions Program investigated ideas for creating more organs: Could technology be developed to 3D-print organs? Could pig organs be View Details

Keywords: April White

October 1998 (Revised December 1999)
Case

Gene Research, the Mapping of Life and the Global Economy

By: Ray A. Goldberg and Juan Enriquez-Cabot

A new firm is being created to speed up the process of mapping humans, animals, and plants by combining gene technology with rapid gene identification to improve the health and well being of the human population and the productivity of crops and animals. How does one... View Details

Keywords: Information Technology; Organizational Structure; Technological Innovation; Business Processes; Health Care and Treatment; Performance Productivity; Welfare; Agribusiness; Genetics; Science-Based Business; Biotechnology Industry; Agriculture and Agribusiness Industry